Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy
NCT07706946
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Lead-Burdened Type 2 Diabetic Nephropathy
Interventions
DRUG:
chelator
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine